Inflammation in myelodysplastic syndrome pathogenesis

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Inflammation is a key driver in the progression of preleukemic myeloid conditions, including clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS), towards myelodysplastic syndromes (MDS).
• It acts as a critical mediator in the complex interactions between genetic, epigenetic, and microenvironmental factors that fuel clonal evolution.
• Somatic mutations in TET2, DNMT3A, and ASXL1, common in CHIP and CCUS, confer a competitive advantage to hematopoietic stem and progenitor cells under inflammatory conditions, promoting their expansion.

Purpose of the Study:

• To review the role of inflammation in the initiation and progression of myelodysplastic syndromes (MDS).
• To highlight the potential of targeting inflammatory pathways for early intervention in MDS.
• To underscore the need for further research into inflammation's impact on clonal evolution in myeloid malignancies.

Main Methods:

• Literature review and synthesis of current research on inflammation, CHIP, CCUS, and MDS.
• Analysis of the interplay between genetic mutations (TET2, DNMT3A, ASXL1) and inflammatory processes.
• Examination of the impact of chronic inflammation on hematopoietic stem cell competition, metabolic reprogramming, and immune deregulation.

Main Results:

• Chronic inflammation promotes the clonal expansion of hematopoietic stem and progenitor cells with specific mutations.
• Inflammation contributes to metabolic reprogramming and immune system dysregulation, favoring malignant clone expansion.
• These inflammatory mechanisms are critical in the transition from preleukemic states to overt MDS.

Conclusions:

• Inflammation is a pivotal factor in the pathogenesis of myelodysplastic syndromes (MDS).
• Therapeutic targeting of inflammatory pathways presents a promising avenue for early intervention in MDS.
• Further elucidation of inflammation's role is crucial for developing novel strategies against MDS initiation and progression.